Afatinib Not Yet Recruiting Phase 2 Trials for Carcinoma, Squamous Cell of Head and Neck Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03088059Biomarker-based Study in R/M SCCHN